Performant Healthcare Inc., a leading provider of technology-driven payment integrity and eligibility verification services, has completed its acquisition by Machinify, a healthcare intelligence firm specializing in data analytics solutions. The transaction, valued at approximately $670 million, marks a significant consolidation in the healthcare payment processing sector. Shareholders of Performant received $7.75 per share in cash consideration upon closing, delivering substantial returns for equity holders.
Strategic Acquisition Strengthens Performant’s Market Position
The combination of Performant’s payment integrity expertise with Machinify’s artificial intelligence capabilities creates a more comprehensive healthcare solutions provider. Performant’s core strength lies in identifying payment discrepancies, verifying patient eligibility, and providing actionable analytics to healthcare organizations seeking to optimize their financial operations. The merger arrangement was completed as originally scheduled, with shares ceasing to trade on Nasdaq following the transaction’s finalization in late 2025.
The equity markets demonstrated strong confidence in Performant’s strategic direction well ahead of the deal closure. When financial analysts first highlighted the opportunity in late April 2025, shares were trading at approximately $2.34. The stock subsequently appreciated to $7.74 per share at transaction close, representing a gain exceeding 230% over the roughly three-month period. This performance reflected investor optimism regarding both the merger terms and Performant’s operational trajectory during the transaction period.
Strong Financial Results Support Transaction Premium
For the second quarter of 2025, Performant reported revenue of approximately $37.8 million, with net income reaching $2.1 million and adjusted EBITDA of approximately $6.2 million. These financial metrics underscored the company’s profitability and operational efficiency, providing validation for the acquisition premium paid by Machinify. The combination positions the merged entity to compete more effectively in healthcare payment integrity and analytics—a market segment increasingly critical as healthcare organizations face mounting pressure to enhance revenue cycle management and reduce payment leakage.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Performant Healthcare Merger Closes at $670 Million; Shares Rally 230% in Months
Performant Healthcare Inc., a leading provider of technology-driven payment integrity and eligibility verification services, has completed its acquisition by Machinify, a healthcare intelligence firm specializing in data analytics solutions. The transaction, valued at approximately $670 million, marks a significant consolidation in the healthcare payment processing sector. Shareholders of Performant received $7.75 per share in cash consideration upon closing, delivering substantial returns for equity holders.
Strategic Acquisition Strengthens Performant’s Market Position
The combination of Performant’s payment integrity expertise with Machinify’s artificial intelligence capabilities creates a more comprehensive healthcare solutions provider. Performant’s core strength lies in identifying payment discrepancies, verifying patient eligibility, and providing actionable analytics to healthcare organizations seeking to optimize their financial operations. The merger arrangement was completed as originally scheduled, with shares ceasing to trade on Nasdaq following the transaction’s finalization in late 2025.
Impressive Stock Performance Reflects Market Confidence
The equity markets demonstrated strong confidence in Performant’s strategic direction well ahead of the deal closure. When financial analysts first highlighted the opportunity in late April 2025, shares were trading at approximately $2.34. The stock subsequently appreciated to $7.74 per share at transaction close, representing a gain exceeding 230% over the roughly three-month period. This performance reflected investor optimism regarding both the merger terms and Performant’s operational trajectory during the transaction period.
Strong Financial Results Support Transaction Premium
For the second quarter of 2025, Performant reported revenue of approximately $37.8 million, with net income reaching $2.1 million and adjusted EBITDA of approximately $6.2 million. These financial metrics underscored the company’s profitability and operational efficiency, providing validation for the acquisition premium paid by Machinify. The combination positions the merged entity to compete more effectively in healthcare payment integrity and analytics—a market segment increasingly critical as healthcare organizations face mounting pressure to enhance revenue cycle management and reduce payment leakage.